halo biotechnologies limited Company Information
Company Number
13074126
Website
-Registered Address
unit 3 181a verulam road, st. albans, AL3 4DR
Industry
Other research and experimental development on natural sciences and engineering
Manufacture of prepared feeds for farm animals
Telephone
-
Next Accounts Due
September 2025
Group Structure
View All
Shareholders
james cox 24%
michael dufton 24%
View Allhalo biotechnologies limited Estimated Valuation
Pomanda estimates the enterprise value of HALO BIOTECHNOLOGIES LIMITED at £0 based on a Turnover of £0 and 0.79x industry multiple (adjusted for size and gross margin).
halo biotechnologies limited Estimated Valuation
Pomanda estimates the enterprise value of HALO BIOTECHNOLOGIES LIMITED at £0 based on an EBITDA of £0 and a 4.12x industry multiple (adjusted for size and gross margin).
halo biotechnologies limited Estimated Valuation
Pomanda estimates the enterprise value of HALO BIOTECHNOLOGIES LIMITED at £189 based on Net Assets of £100 and 1.89x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Halo Biotechnologies Limited Overview
Halo Biotechnologies Limited is a live company located in st. albans, AL3 4DR with a Companies House number of 13074126. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in December 2020, it's largest shareholder is james cox with a 24% stake. Halo Biotechnologies Limited is a startup, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Halo Biotechnologies Limited Health Check
There is insufficient data available to calculate a health check for Halo Biotechnologies Limited. Company Health Check FAQs
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Halo Biotechnologies Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Halo Biotechnologies Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Halo Biotechnologies Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Halo Biotechnologies Limited
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Halo Biotechnologies Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Halo Biotechnologies Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Halo Biotechnologies Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Halo Biotechnologies Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Halo Biotechnologies Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Halo Biotechnologies Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Halo Biotechnologies Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Halo Biotechnologies Limited
- - Industry AVG
HALO BIOTECHNOLOGIES LIMITED financials
Halo Biotechnologies Limited's latest turnover from December 2023 is estimated at 0 and the company has net assets of £100. According to their latest financial statements, we estimate that Halo Biotechnologies Limited has no employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | |
---|---|---|---|
Turnover | |||
Other Income Or Grants | |||
Cost Of Sales | |||
Gross Profit | |||
Admin Expenses | |||
Operating Profit | |||
Interest Payable | |||
Interest Receivable | |||
Pre-Tax Profit | |||
Tax | |||
Profit After Tax | |||
Dividends Paid | |||
Retained Profit | |||
Employee Costs | |||
Number Of Employees | |||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | |
---|---|---|---|
Tangible Assets | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 |
Investments & Other | 100 | 100 | 100 |
Debtors (Due After 1 year) | 0 | 0 | 0 |
Total Fixed Assets | 100 | 100 | 100 |
Stock & work in progress | 0 | 0 | 0 |
Trade Debtors | 0 | 0 | 0 |
Group Debtors | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 |
Cash | 0 | 0 | 0 |
misc current assets | 0 | 0 | 0 |
total current assets | 0 | 0 | 0 |
total assets | 100 | 100 | 100 |
Bank overdraft | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 |
Trade Creditors | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 |
total current liabilities | 0 | 0 | 0 |
loans | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 |
provisions | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 |
total liabilities | 0 | 0 | 0 |
net assets | 100 | 100 | 100 |
total shareholders funds | 100 | 100 | 100 |
Dec 2023 | Dec 2022 | Dec 2021 | |
---|---|---|---|
Operating Activities | |||
Operating Profit | |||
Depreciation | 0 | 0 | 0 |
Amortisation | 0 | 0 | 0 |
Tax | |||
Stock | 0 | 0 | 0 |
Debtors | 0 | 0 | 0 |
Creditors | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 |
Cash flow from operations | |||
Investing Activities | |||
capital expenditure | |||
Change in Investments | 0 | 0 | 100 |
cash flow from investments | |||
Financing Activities | |||
Bank loans | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 |
share issue | |||
interest | |||
cash flow from financing | |||
cash and cash equivalents | |||
cash | 0 | 0 | 0 |
overdraft | 0 | 0 | 0 |
change in cash | 0 | 0 | 0 |
halo biotechnologies limited Credit Report and Business Information
Halo Biotechnologies Limited Competitor Analysis
Perform a competitor analysis for halo biotechnologies limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other startup companies, companies in AL3 area or any other competitors across 12 key performance metrics.
halo biotechnologies limited Ownership
HALO BIOTECHNOLOGIES LIMITED group structure
Halo Biotechnologies Limited has no subsidiary companies.
Ultimate parent company
HALO BIOTECHNOLOGIES LIMITED
13074126
halo biotechnologies limited directors
Halo Biotechnologies Limited currently has 5 directors. The longest serving directors include Mr James Cox (Dec 2020) and Professor Colin Webb (Dec 2020).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr James Cox | England | 41 years | Dec 2020 | - | Director |
Professor Colin Webb | 70 years | Dec 2020 | - | Director | |
Mr David Lux | England | 59 years | Dec 2020 | - | Director |
Dr Gary Robinson | England | 60 years | Dec 2020 | - | Director |
Mr Ivan Turland | England | 55 years | Dec 2020 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
100
0%
total assets
100
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
halo biotechnologies limited company details
company number
13074126
Type
Private limited with Share Capital
industry
72190 - Other research and experimental development on natural sciences and engineering
10910 - Manufacture of prepared feeds for farm animals
01610 - Support activities for crop production
incorporation date
December 2020
age
4
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
-
address
unit 3 181a verulam road, st. albans, AL3 4DR
Bank
-
Legal Advisor
-
halo biotechnologies limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to halo biotechnologies limited.
halo biotechnologies limited Companies House Filings - See Documents
date | description | view/download |
---|